Clinical trials: Molecular Targeted Therapies
Rheumatoid Arthritis
Comparative Effectiveness of Targeted Therapy in RA Patients
The objective of a multicenter prospective observational study is to compare effectiveness and safety of biologic disease-modifying antirheumatic drugs and small molecular inhibitors in patients with moderately to severely active…
- Trial name
- NCT04449224
- Testing
- Adalimuab, Etanercept, Tocilizumab, or Abatacept, Tofacitinib or Baricitinib
- Where
- South Korea
- Volunteers
- 506 people
- Sponsor
- Hanyang University
Breast Cancer
Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy
The purpose of this study is to see what kinds of breast tumors will respond to lapatinib. Lapatinib is an experimental medicine which may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
- Trial name
- NCT00343759
- Testing
- Lapatinib
- Where
- United States
- Sponsor
- University of Pennsylvania